[Inhibitory effect of wogonin on human colorectal cancer cell SW480 based on network pharmacology]

Yan-Ping Li1, Yi-Ting Gong1, Jia-Xin Wang2

  • 1School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 100029, China.

Insights

Wogonin, a compound from Scutellaria baicalensis, inhibits colorectal cancer cell growth by affecting the Wnt/β-catenin pathway. This study identifies key protein targets, offering insights for anti-colon cancer drug development.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Network Pharmacology

Background:

  • Wogonin, a key component of Scutellaria baicalensis, exhibits significant anti-cancer properties.
  • The molecular mechanisms underlying wogonin's anti-cancer effects, particularly in colorectal cancer, remain largely unelucidated.
  • Identifying molecular targets is crucial for developing wogonin as an anti-colon cancer therapeutic.

Purpose of the Study:

  • To investigate the potential molecular targets and pathways of wogonin in inhibiting colorectal cancer growth using network pharmacology.
  • To validate the anti-proliferative effects and molecular mechanism of wogonin in SW480 colorectal cancer cells.
  • To identify specific protein targets involved in wogonin's anti-cancer activity.

Main Methods:

  • Network pharmacology was employed to predict potential targets and pathways.
  • Pharmacological assays were conducted to assess wogonin's effect on SW480 cell proliferation.
  • Western blot analysis was used to examine the expression levels of key proteins in the Wnt/β-catenin pathway.

Main Results:

  • Network pharmacology identified the Wnt/β-catenin pathway as a key mechanism for wogonin's anti-cancer activity.
  • Wogonin significantly inhibited SW480 cell proliferation in a concentration-dependent manner and induced G1 phase arrest.
  • Wogonin down-regulated CTNNB1 (β-catenin), BIRC5 (survivin), and GSK3B, while up-regulating BAX expression.

Conclusions:

  • Wogonin effectively inhibits colorectal cancer cell proliferation by modulating the Wnt/β-catenin signaling pathway.
  • Key molecular targets including CTNNB1, BIRC5, GSK3B, and BAX were identified.
  • This research provides a theoretical foundation for the clinical application of wogonin in anti-colon cancer drug discovery.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.2K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.7K